Form 483

Sunrise International Group Form 483, 2024-03-15

FDA issued a Form 483 to Sunrise International Group on 2024-03-15 with 8 public-safe observations.

483· Form 483 issuedFoods & Cosmetics8 observations

Sunrise International Group · Hayward, United States · Issued March 15, 2024

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Mar 2024
21 CFR 1.502(a)

Develop FSVP

Cited by Steven B Chiu

15 Mar 2024
21 CFR 1.504(b)(1)

Hazard analysis biological, chemical, physical

Cited by Steven B Chiu

15 Mar 2024
21 CFR 1.504(d)

Document review entity's hazard analysis

Cited by Steven B Chiu

15 Mar 2024
21 CFR 1.505(a)(2)

Evaluation - performance, risk

Cited by Steven B Chiu

15 Mar 2024
21 CFR 1.506(a)(1)

Approved supplier procedures - importer established

Cited by Steven B Chiu

Inspected site

SISunrise International GroupHayward, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1.502(a)Cited across public-safe Form 483 observations1x
21 CFR 1.504(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 1.504(d)Cited across public-safe Form 483 observations1x
21 CFR 1.505(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 1.506(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 1.506(b)Cited across public-safe Form 483 observations1x
21 CFR 1.506(d)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 1.506(e)(1)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere